Gadeta
Latest round
- Series A
Last raised
- Mar 2016
Total raised
- $7.6M
Investors
- 3
About Gadeta
V. focuses on creating innovative cancer therapies., a portfolio company of Bristol-Myers Squibb Company.Gadeta focuses on developing innovative immunotherapy solutions aimed at enhancing the treatment of various cancers. The company's core offerings center around its proprietary technology that harnesses the power of gamma delta T cells in the immune system, specifically targeting tumor cells. This approach is designed to improve patient outcomes by increasing the efficacy and precision of cancer treatments, thereby addressing significant unmet clinical needs.The revenue model for Gadeta is structured around partnerships with healthcare institutions and potential licensing agreements. The company engages in B2B transactions, collaborating with hospitals and research organizations that incorporate its immunotherapy products into their treatment protocols. Revenue generation occurs through these partnerships, where clients may pay for access to Gadeta's therapies and related technologies. While specific pricing plans are not disclosed, flagship products associated with the company are likely to be integral to the revenue streams.Following the recent acquisition by Clade Therapeutics, Gadeta's strategic future involves leveraging its preclinical cell therapy programs to enhance the development of stem cell-based medicines. This acquisition allows Clade to access Gadeta's innovative technology, thereby expanding its capabilities in the oncology sector. Future growth will also focus on integrating Gadeta’s therapies into broader clinical applications, with targeted plans for expansion into additional markets as part of Clade's strategic roadmap.
Who invested in Gadeta
3 investors across 1 round
See all investors in Gadeta
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 29, 2016
Amount
$7.6M
Investors
Questions about Gadeta
Who invested in Gadeta?
Gadeta has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gadeta raised?
Gadeta has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Gadeta last raise money?
Gadeta's most recent round on record is a Series A, in Mar 2016.
What does Gadeta do?
Gadeta is a biotechnology company.
Where is Gadeta headquartered?
Gadeta is headquartered in Utrecht, Netherlands.
Which VCs invest in companies like Gadeta?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Gadeta's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Gadeta? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.